Evergraf 0.25mg Tablet

Discover how Evergraf 0.25mg Tablet, formulated by Panacea Biotec Pharma Ltd with Everolimus (0.25mg), can assist with Breast cancer,Prevention of organ rejection in transplant patients,Lung cancer,Pancreatic cancer,Kidney cancer. This page provides a comprehensive overview of this medication, including its primary applications and further detailed information to support your understanding. Feel free to add it to your favorites or compare it with other available options.

MRP: ₹ 700.59
Packing: 10.0 tablets in 1 strip
Salt Combination: Everolimus (0.25mg)
Brand: Panacea Biotec Pharma Ltd
Uses: Breast cancer,Prevention of organ rejection in transplant patients,Lung cancer,Pancreatic cancer,Kidney cancer

Description

Evergraf 0.25mg Tablet is used for the prevention of organ rejection in transplant patients
It regulates the body’s immune response, so the body can accept the new organ
It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney
Evergraf 0.25mg Tablet must be taken in a dose and duration as per the prescription
It can be taken with or without food but make sure to take it at about the same time every day
An overdose of this medicine may have serious side effects on the body.
The common side effects of this medicine include infection, fever, cough, fatigue, diarrhea, and upper respiratory infection
If any of the side effects persist or bother you, consult the doctor immediately
Inform the doctor immediately if you experience any allergic reactions (rash, shortness of breath, coughing, swelling, etc.)
Always seek medical advice if you have increased thirst or increased frequency of urination, suffer from shortness of breath, cough or fever, or need to receive any vaccination after taking this medication.
Before taking this medicine, it is important to consult your doctor if you have any ongoing medication for any underlying disease
Pregnant and breastfeeding women must inform the doctor prior to the initiation of this treatment
During the treatment, your doctor may advise you for some laboratory tests to know the effects of the medicine in the body
It may affect male or female fertility, so consult the doctor if you are planning to have a child.

Cautions

Liver:	CAUTION: Evergraf 0.25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Evergraf 0.25mg Tablet may be needed. Please consult your doctor. Use of Evergraf 0.25mg Tablet is not recommended in patients with severe liver disease.
Kidney:	SAFE IF PRESCRIBED: Evergraf 0.25mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Evergraf 0.25mg Tablet is recommended.
Driving:	UNSAFE: Evergraf 0.25mg Tablet may cause side effects which could affect your ability to drive.^As fatigue is a common side effect with Evergraf 0.25mg Tablet and this may affect your ability to drive
Breast feeding:	CONSULT YOUR DOCTOR: Evergraf 0.25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnency:	CONSULT YOUR DOCTOR: Evergraf 0.25mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Alcohol:	CONSULT YOUR DOCTOR: It is not known whether it is safe to consume alcohol with Evergraf 0.25mg Tablet. Please consult your doctor.
Drug Action:	Immunosuppressant- mTOR inhibitors
Therapeutic class:	ANTI NEOPLASTICS
Habit Forming:	No
Chemical Class:	Macrolide Lactams

Uses of Evergraf 0.25mg Tablet

In Prevention of organ rejection in transplant patients Evergraf 0.25mg Tablet is used with other medications to prevent organ transplant rejection
Rejection usually happens due to attack by the immune system of the person receiving the transplanted organ on the transplant itself, in people who are receiving any organ transplants, like kidney, liver, heart etc
This medicine reduces the activity of a person's own immune system and prevents any such rejection.